Fig. 2 | Scientific Reports

Fig. 2

From: Selection of anti-cytokine biologics by pretreatment levels of serum leucine-rich alpha-2 glycoprotein in patients with inflammatory bowel disease

Fig. 2

Effectiveness of UST or anti-TNF treatment for patients with IBD using median 0w-CRP or 0w-Alb. The proportion of CR in patients with low- or high-CRP at week 8 of treatment with UST (a) and anti-TNF treatment (b). The proportion of CR in patients with low- or high-Alb at week 8 of treatment with UST (c) and anti-TNF treatment (d). The low-CRP group is defined as 0w-CRP < 0.19 mg/dL and the high-CRP group as ≥ 0.19 mg/dL. The low-Alb group is defined as 0w-Alb < 3.9 g/dL and the high-Alb group as ≥ 3.9 g/dL.

Back to article page